Skip to main content
logo
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
79.03
+1.53 (1.97%)
At close: Mar 13, 2026, 4:00 PM EDT
79.03
0.00 (0.00%)
After-hours: Mar 13, 2026, 4:52 PM EDT

Kymera Therapeutics Revenue

In the year 2025, Kymera Therapeutics had annual revenue of $39.21M, down -16.70%. Kymera Therapeutics had revenue of $2.87M in the quarter ending December 31, 2025, a decrease of -61.18%.

Revenue (ttm)
$39.21M
Revenue Growth
-16.70%
P/S Ratio
164.55
Revenue / Employee
$164,752
Employees
238
Market Cap
6.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202539.21M-7.86M-16.70%
Dec 31, 202447.07M-31.52M-40.11%
Dec 31, 202378.59M31.77M67.84%
Dec 31, 202246.83M-26.01M-35.71%
Dec 31, 202172.83M38.80M114.00%
Dec 31, 202034.03M31.10M1,059.99%
Dec 31, 20192.93M--
Dec 31, 20182.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Halozyme Therapeutics1.40B
Mirum Pharmaceuticals521.31M
Krystal Biotech389.13M
Rhythm Pharmaceuticals189.76M
Cytokinetics88.04M
Protagonist Therapeutics46.02M
Arcellx22.29M
Xenon Pharmaceuticals7.50M
Revenue Rankings

KYMR News

More News